247 related articles for article (PubMed ID: 24470255)
21. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
[TBL] [Abstract][Full Text] [Related]
22. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
23. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
24. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
25. Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.
Tran CW; Saibil SD; Le Bihan T; Hamilton SR; Lang KS; You H; Lin AE; Garza KM; Elford AR; Tai K; Parsons ME; Wigmore K; Vainberg MG; Penninger JM; Woodgett JR; Mak TW; Ohashi PS
J Immunol; 2017 Dec; 199(12):4056-4065. PubMed ID: 29109121
[TBL] [Abstract][Full Text] [Related]
26. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK.
Lee SE; Chung WJ; Kwak HB; Chung CH; Kwack KB; Lee ZH; Kim HH
J Biol Chem; 2001 Dec; 276(52):49343-9. PubMed ID: 11675379
[TBL] [Abstract][Full Text] [Related]
28. Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo.
Kim JY; Oh HM; Kwak SC; Cheon YH; Lee MS; Rho MC; Oh J
Biol Pharm Bull; 2015; 38(1):66-74. PubMed ID: 25744460
[TBL] [Abstract][Full Text] [Related]
29. PTEN regulation by the Akt/GSK-3β axis during RANKL signaling.
Jang HD; Noh JY; Shin JH; Lin JJ; Lee SY
Bone; 2013 Jul; 55(1):126-31. PubMed ID: 23419777
[TBL] [Abstract][Full Text] [Related]
30. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
Sankar U; Patel K; Rosol TJ; Ostrowski MC
J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
[TBL] [Abstract][Full Text] [Related]
31. Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation.
Qu X; Li Y; Liu J; Xu L; Zhang Y; Hu X; Hou K; Liu Y
Mol Cell Biochem; 2010 Jul; 340(1-2):107-14. PubMed ID: 20177738
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
33. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
[TBL] [Abstract][Full Text] [Related]
34. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
[TBL] [Abstract][Full Text] [Related]
35. Src kinase activity is essential for osteoclast function.
Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation.
Fan X; Xiong H; Wei J; Gao X; Feng Y; Liu X; Zhang G; He QY; Xu J; Liu L
Sci Rep; 2015 Dec; 5():17732. PubMed ID: 26638989
[TBL] [Abstract][Full Text] [Related]
37. Receptor activator of NF-kappaB (RANK) cytoplasmic motif, 369PFQEP373, plays a predominant role in osteoclast survival in part by activating Akt/PKB and its downstream effector AFX/FOXO4.
Liu W; Wang S; Wei S; Sun L; Feng X
J Biol Chem; 2005 Dec; 280(52):43064-72. PubMed ID: 16260781
[TBL] [Abstract][Full Text] [Related]
38. Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1.
Tu Q; Zhang J; Dong LQ; Saunders E; Luo E; Tang J; Chen J
J Biol Chem; 2011 Apr; 286(14):12542-53. PubMed ID: 21300805
[TBL] [Abstract][Full Text] [Related]
39. Extracellular acidosis accelerates bone resorption by enhancing osteoclast survival, adhesion, and migration.
Ahn H; Kim JM; Lee K; Kim H; Jeong D
Biochem Biophys Res Commun; 2012 Feb; 418(1):144-8. PubMed ID: 22244876
[TBL] [Abstract][Full Text] [Related]
40. Distinct roles of p130Cas and c-Cbl in adhesion-induced or macrophage colony-stimulating factor-mediated signaling pathways in prefusion osteoclasts.
Nakamura I; Rodan GA; Duong LT
Endocrinology; 2003 Nov; 144(11):4739-41. PubMed ID: 12959979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
